DABRAFENIB MESYLATE, 95%, 250mg

4-(2,6-Difluorophenyl)-4-oxobutyric acid, 97.0%, 2g

2-(4-Bromo-1h-pyrazol-1-yl)pyrazine, 97%, 5g

Ethyl 4-ethoxyquinoline-7-carboxylate, 95.0%, 1g

(E)-3-(Thiazol-4-yl)acrylic acid, 98%, 25g

trans 2-Butene-1,4-dicarboxylic acid, 95%, 1g

ALLYL METHYL SULFIDE, 95%, 5g

Phenol, m-(methylthio)-, 98%, 1g

6-Benzyl-5,7-dihydro-5,7-dioxopyrrolo[3,4-b]pyridine, 95.0%, 25g

Genistein, >98%, 50g

4-(tert-Butyldimethylsiloxy)phenol, 98%, 10g

1-(Methylsulfonyl)-4-(5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyridin-3-yl)piperazine, 98%, 500mg

Isobutyl Methacrylate (stabilized with HQ)>98.0%(GC)500mL